Comment on “PCNA and Ki67: Prognostic proliferation markers for oral cancer”

Comment on “PCNA and Ki67: Prognostic proliferation markers for oral cancer”

Saved in:

Bibliographic Details
Main Author:	Muthupandian Saravanan
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024003662
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers
by: José M. Lopes, et al.
Published: (1998-01-01)

The importance of Ki-67 proliferation index in small cell lung cancer
by: Seda Beyhan Sağmen, et al.
Published: (2025-01-01)

PCNA, Ki-67, p53, bcl-2 and Prognosis in Intraoral Squamous Cell Carcinoma of the Head and Neck
by: Karin Nylander, et al.
Published: (1997-01-01)

Comment on “Exploring PD-1 methylation in oral cancer: A crucial frontier in immunotherapy”
by: Muthupandian Saravanan
Published: (2024-09-01)

Study of morphology with assessment of expression of proliferation marker Ki67 antigen and P53 protein in lesions of gall bladder
by: Ojasvi Ramesh, et al.
Published: (2024-04-01)

Prognostic relevance of Ki-67 and P16/INK4a markers in histological diagnosis of cervical dysplasia
by: T. A. Dimitriadi, et al.
Published: (2020-03-01)

Comment on “Salivary exosomes as potential biomarkers in cancer”
by: Muthupandian Saravanan
Published: (2024-09-01)

Immunoexpression of P16 and Ki 67 in oral squamous cell carcinoma: Association with clinicopathological parameters.
by: Shadan Mohamad Omer, et al.
Published: (2020-12-01)

The Impact of p53 and Ki67 Expression in Endometrial Cancer and its Effect on Survival
by: Zekiye Sahin, et al.
Published: (2022-03-01)

Letter to the editor: Comment on “the predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis”
by: Muthupandian Saravanan
Published: (2024-09-01)

Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma
by: Bo Wang, et al.
Published: (2022-01-01)

Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01)

Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
by: Wang Wenhui, et al.
Published: (2024-12-01)

Oral sex associated with the prevalence of human papillomavirus and oropharyngeal cancer: Is it the leading risk factor for head and neck cancers in the modern society?
by: Muthupandian Saravanan
Published: (2024-06-01)

Advancements in cancer research: 3D bioprinting as an optimal oral tumor model
by: Aruchamy Mohanprasanth, et al.
Published: (2024-03-01)

The value of multiparametric MRI radiomics and machine learning in predicting preoperative Ki-67 expression level in breast cancer
by: Yan Lu, et al.
Published: (2025-01-01)

Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
by: Clarice F. E. M. Osório, et al.
Published: (2025-01-01)

Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
by: Sumaira Siddiqui
Published: (2024-04-01)

Ki-67 and CDK1 control the dynamic association of nuclear lipids with mitotic chromosomes
by: Hsiao-Tang Hu, et al.
Published: (2025-01-01)

Comment on “TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)”
by: Muthupandian Saravanan
Published: (2024-09-01)

Multi-institutional evaluation comparing guidance from International Ki67 Working Group vs National Health Commission of China on immunohistochemistry-based Ki67 assessment alongside the Quantitative Dot Blot method
by: Yin Wang, et al.
Published: (2025-01-01)

Potential value of novel multiparametric MRI radiomics for preoperative prediction of microsatellite instability and Ki-67 expression in endometrial cancer
by: Zhichao Wang, et al.
Published: (2025-01-01)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
by: Jan P. A. Baak, et al.
Published: (2005-01-01)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
by: Rosella Silvestrini
Published: (2005-01-01)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
by: Arnold-Jan Kruse, et al.
Published: (2004-01-01)

Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer
by: Liying Zhang, et al.
Published: (2023-01-01)

Predictive and Prognostic Molecular Markers of Oral Cancers and Potential Therapeutic Agents Targeting These Markers
by: Shilpa Jain, et al.
Published: (2024-08-01)

H. Wendl Leaf Metabolites Potentiate the Radiosensitivity of Hepatocellular Carcinoma Through Ki67 and PARP Inhibition
by: Nabil M. Selim PhD, et al.
Published: (2025-01-01)

Vitamin D Receptor, Retinoid X Receptor, Ki-67, Survivin, and Ezrin Expression in Canine Osteosarcoma
by: John Davies, et al.
Published: (2012-01-01)

Correlation between Ki-67 labeling index and mitotic index in Head and neck squamous cell carcinoma
by: Das C. K Deepa, et al.
Published: (2024-12-01)

Ｋｉ－６７在木村病患者中的表达和复发相关因素分析
Published: (2014-01-01)

A multi-modal deep learning model for prediction of Ki-67 for meningiomas using pretreatment MR images
by: Chaoyue Chen, et al.
Published: (2025-01-01)

Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
by: Dhinakaran Paranchodi, et al.
Published: (2024-09-01)

Comparison of the Manual, Semiautomatic, and Automatic Selection and Leveling of Hot Spots in Whole Slide Images for Ki-67 Quantification in Meningiomas
by: Zaneta Swiderska, et al.
Published: (2015-01-01)

The Role of PCNA Posttranslational Modifications in Translesion Synthesis
by: Montaser Shaheen, et al.
Published: (2010-01-01)

Predicting recurrence of non-muscle invasive bladder urothelial carcinoma: predictive value of the optimal cut-off value of Ki67
by: Rende Peng, et al.
Published: (2025-01-01)

Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
by: Vandana Puri, et al.
Published: (2011-01-01)

Inmunolocalización de citoqueratina 14, 19 y Ki-67 en el epitelio de pacientes con agrandamiento gingival
by: Víctor Simancas-Escorcia, et al.
Published: (2023-01-01)

Targeting compensatory proliferation signals in oral cancer
by: Loganathan Kavitha, et al.
Published: (2024-07-01)

Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA
by: Tianzhao Du, et al.
Published: (2024-12-01)